up to now several years, the united kingdom has witnessed a revolution in clinical bodyweight‑decline therapies — with the introduction of semaglutide (Wegovy®) on the developing attractiveness of tirzepatide (Mounjaro®). Now, An additional identify is drawing notice in each scientific and commun